CAPTRUST Financial Advisors’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,059
Closed -$222K 2644
2023
Q2
$222K Buy
10,059
+130
+1% +$2.74K ﹤0.01% 2188
2023
Q1
$216K Buy
+9,929
New +$223K ﹤0.01% 2002
2022
Q4
Sell
-9,348
Closed -$213K 2072
2022
Q3
$213K Buy
9,348
+5,399
+137% +$116K ﹤0.01% 1784
2022
Q2
$55K Buy
3,949
+3,464
+714% +$50.8K ﹤0.01% 2668
2022
Q1
$11K Buy
485
+90
+23% +$2.37K ﹤0.01% 3734
2021
Q4
$15K Sell
395
-216
-35% -$9.27K ﹤0.01% 3469
2021
Q3
$26K Buy
611
+65
+12% +$3.13K ﹤0.01% 2987
2021
Q2
$24K Buy
546
+288
+112% +$10.1K ﹤0.01% 2976
2021
Q1
$9K Hold
258
﹤0.01% 3476
2020
Q4
$10K Hold
258
﹤0.01% 2559
2020
Q3
$8K Sell
258
-250
-49% -$5.4K ﹤0.01% 2355
2020
Q2
$8K Buy
+508
New +$7K ﹤0.01% 2247

Other funds holding BLFS

CAPTRUST Financial Advisors's BLFS Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 10,059 shares — an estimated $222K sold.

CAPTRUST Financial Advisors first reported a position in BLFS in Q2 2020 and held it in 12 quarters. The position peaked at $222K in Q2 2023. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • CAPTRUST Financial Advisors reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 10,059 BioLife Solutions shares in Q3 2023, an estimated $222K.
  • CAPTRUST Financial Advisors first reported a position in BioLife Solutions in Q2 2020 and held it in 12 quarters.
  • CAPTRUST Financial Advisors's BioLife Solutions position peaked at $222K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.